Blog by Sanwariya Packaging

Your Trusted Partner in Packaging

Learn About Our Vision for the Future And Grow with Us.

Your Trusted Partner in Pharma Packaging

Learn about our vision for the future and grow with us.

Your Trusted Partner
in Pharma Packaging

Learn about our vision for the future and grow with us.

Know More
Search
Categories
Categories
Popular Tags

Tag: moisture barrier

Packaging needs for new and emerging biologic drugs

Biologic medicines are becoming one of the fastest-growing segments of the pharmaceutical industry. Unlike traditional small-molecule drugs, biologics are complex molecules derived from living systems. They include therapies such as monoclonal antibodies, vaccines, recombinant proteins, and advanced cell-based treatments. 

Because of their molecular complexity, biologics are often highly sensitive to environmental conditions. Factors such as moisture, oxygen, temperature, and light can influence their stability and effectiveness. 

As a result, packaging plays a critical role in protecting biologic medicines throughout manufacturing, storage, and distribution. Selecting the right packaging materials helps maintain product integrity while ensuring compliance with strict regulatory stability requirements. 

Pharmaceutical aluminum foils used in blister and secondary packaging structures can contribute to these protective systems by providing strong barrier performance against moisture and oxygen. 

This blog explores the stability challenges associated with biologic therapies, explains the environmental sensitivities of these molecules, and discusses how foil-based packaging structures can support safe and stable biologic distribution.

Why Biologic Medicines Require Specialized Packaging

Biologics differ significantly from conventional pharmaceutical compounds. Traditional drugs are typically composed of relatively small and chemically stable molecules. In contrast, biologics consist of large, complex protein structures or biological materials that can degrade more easily when exposed to environmental stress.

Because of their structure, biologic products may be sensitive to several external factors.

  • Temperature fluctuations
  • Moisture exposure
  • Oxygen penetration
  • Light exposure
  • Mechanical stress during transportation

Even small environmental variations can alter the molecular structure of a biologic therapy. These changes may reduce therapeutic effectiveness or lead to aggregation, denaturation, or degradation of the active ingredient.

Packaging systems therefore need to maintain a stable protective environment around the product throughout its shelf life.

Stability Challenges in Biologic Formulations

Maintaining stability is one of the most significant challenges in biologic drug development. Protein-based molecules are particularly sensitive to environmental conditions that might not affect traditional pharmaceuticals.

Several stability risks are commonly evaluated during biologic product development.

  • Protein denaturation caused by temperature changes
  • Oxidation reactions triggered by oxygen exposure
  • Moisture-driven degradation in sensitive formulations
  • Structural changes caused by prolonged storage conditions
Biologic medicines are often stored in refrigerated environments and transported through controlled cold-chain systems. However, temperature control alone is not always sufficient. Packaging materials must also protect the product from environmental gases and humidity that may affect long-term stability. 

Barrier packaging therefore plays a supporting role in maintaining product quality.

Sensitivity to Moisture and Oxygen

Moisture and oxygen are two environmental factors that can significantly influence the stability of biologic therapies. Even minimal levels of water vapor or oxygen exposure may accelerate degradation reactions.

Moisture can affect biologic formulations in several ways, like:

  • Hydrolysis reactions that degrade molecular structures
  • Changes in formulation stability
  • Reduced shelf life of sensitive dosage forms

Oxygen exposure can also lead to oxidation reactions that alter protein structure and reduce therapeutic activity. Because of these risks, packaging materials for biologic medicines are often selected based on their ability to provide strong barrier protection against both moisture and oxygen ingress.

Role of Aluminum Foil in Biologic Packaging

Aluminum foil is widely recognized for its exceptional barrier properties. Unlike many plastic materials, aluminum creates a near-complete barrier against moisture, oxygen, and light.

When used in pharmaceutical packaging structures, foil can help maintain a stable environment around sensitive dosage forms.

Key protective properties of aluminum foil include:

  • Extremely low permeability to moisture
  • Strong resistance to oxygen transmission
  • Protection against light exposure
  • Compatibility with blister packaging systems

These characteristics make foil-based materials suitable for packaging certain biologic dosage forms that require enhanced environmental protection.

Foil structures are often used in blister foils or advanced formats such as multi-layer foils where maintaining barrier integrity is essential.

Foil Applications in Biologic Dosage Forms

Although many biologic therapies are packaged in vials, syringes, or cartridges, blister packaging can still play a role in protecting specific dosage formats or associated components.

Examples may include:

  • Unit-dose biologic tablets or capsules containing stabilized biologic compounds
  • Packaging for biologic combination products
  • Protective packaging for diagnostic kits and biologic reagents
  • Secondary packaging layers for sensitive delivery systems

In these applications, aluminum foil lidding materials help prevent environmental exposure while maintaining packaging integrity during storage and distribution.

Packaging development teams evaluate foil structures carefully to ensure compatibility with the product’s stability profile, including the use of cold forming foils where higher barrier protection is required.

Importance of Secondary Packaging Pairing

In many cases, biologic packaging systems rely on a combination of primary and secondary protective layers.

Primary packaging may include containers such as vials, prefilled syringes, or blister cavities that directly hold the product. Secondary packaging then provides an additional protective barrier against environmental stress.

Foil-based materials may be incorporated into these secondary packaging systems to improve overall protection.

Examples of secondary packaging functions include:

  • Providing additional moisture and oxygen barriers
  • Protecting primary containers during transportation
  • Shielding products from light exposure
  • Supporting tamper-evident packaging requirements
Combining primary containers with high-performance secondary packaging helps create a more robust stability system for biologic products.

Cold-Chain Considerations for Biologic Packaging

Many biologic medicines require temperature-controlled transportation to maintain stability. Cold-chain logistics are therefore an essential part of biologic distribution.

However, temperature management alone does not eliminate all stability risks. Environmental exposure during handling, storage, or transportation may still affect product integrity.

Packaging materials used for biologics must therefore perform reliably under cold-chain conditions.

Key considerations may include:

  • Maintaining barrier integrity at low temperatures
  • Preventing moisture ingress during condensation events
  • Maintaining structural stability during refrigerated storage
Foil-based packaging materials are often evaluated for their performance in these conditions to ensure consistent protection throughout the supply chain, supported by robust production systems such as those outlined in the infrastructure.

Regulatory Expectations for Biologic Stability

Regulatory authorities require pharmaceutical companies to demonstrate that biologic products remain stable under recommended storage conditions. Packaging materials must support these stability profiles throughout the product’s approved shelf life.

Regulatory documentation for biologic packaging may include:

  • Stability testing under controlled environmental conditions
  • Validation of packaging barrier properties
  • Documentation of packaging material specifications
  • Compatibility studies between packaging materials and the product

Regulatory agencies expect packaging systems to maintain product integrity during the full lifecycle of the medicine, including manufacturing, transportation, storage, and patient use.

Selecting appropriate barrier materials is therefore an important part of regulatory compliance.

Supporting the Protection of Advanced Therapies

Biologic medicines represent an important advancement in modern healthcare. However, their complex molecular structures require carefully designed packaging systems to maintain stability and effectiveness.

Protection against moisture, oxygen, and environmental stress is essential for maintaining the quality of biologic therapies. Aluminum foil materials can contribute to these protective systems by providing strong barrier performance and compatibility with pharmaceutical packaging technologies.

By combining appropriate primary containers with reliable secondary packaging structures, pharmaceutical companies can create packaging systems that help safeguard biologic medicines throughout global distribution.

Sanwariya Packaging manufactures pharmaceutical aluminum foils designed to provide consistent barrier protection, reliable sealing performance, and compatibility with modern pharmaceutical packaging systems. With controlled manufacturing processes and advanced capabilities supported by its infrastructure, Sanwariya Packaging supports pharmaceutical companies developing packaging solutions that help maintain the stability of sensitive medicines during storage and international distribution.

For further discussions or requirements, you can get in touch with us or directly request a quote.

How to Protect Emerging Biologic Therapies with Advanced Packaging

Author

Jay Wadhwani

Read More
Pharmaceutical blister packs and aluminum foil rolls used for seal integrity in packaging

Pharmaceutical packaging must ensure that medicines remain stable, effective, and safe throughout their lifecycle. Among the most widely used formats, blister and strip packaging rely heavily on one critical factor: seal integrity.

While sealing performance is influenced by multiple variables, one of the most decisive factors is the quality and consistency of the aluminum foil used.

If seals are compromised due to material inconsistencies or poor coating performance, moisture, oxygen, or contaminants can enter the pack—leading to product degradation well before expiry. For pharmaceutical manufacturers, this directly impacts product quality, compliance, and market reputation.

This article focuses on how foil properties and sealing compatibility drive seal integrity in blister and strip packaging.

Why Seal Integrity Is a Material-Driven Parameter

Both blister and strip packaging depend on sealed structures for protection.

Blister Packaging

  • Forming film (PVC or similar)
  • Aluminum lidding foil with heat-seal coating

Strip Packaging

  • Laminated aluminum foils (with polymer layers such as LDPE)

In both cases, the seal is only as reliable as the material interface between layers.

Even when sealing parameters are optimized, poor foil quality can lead to:

  • inconsistent bonding
  • micro-leakage paths
  • reduced barrier performance
  • variability across production batches
For sensitive pharmaceutical formulations, such inconsistencies can result in stability failures and compliance risks.

Seal Strength in Blister Packaging

Blister packaging uses non-peelable seals, where the lidding foil is bonded permanently to the forming film.

The performance of this seal depends largely on the heat-seal coating applied to the aluminum foil.

Critical material-driven factors include:

  • uniform coating thickness across the foil surface
  • consistent adhesion properties with the forming film
  • resistance to channel formation or weak spots
  • compatibility with different blister substrates (PVC, PVDC, etc.)

Unlike strip packaging, the seal is not designed to be peeled. Instead, it must maintain integrity until the product is accessed via push-through.

Peel Strength in Strip (Laminated) Packaging

Peel strength is a relevant parameter in strip packaging, where laminated foil structures are used.

In these systems, aluminum foil is combined with polymer layers (such as LDPE), enabling controlled peel-open functionality.

Peel strength depends on:

  • the lamination quality between layers
  • the polymer composition and thickness
  • the consistency of bonding across the laminate

A well-designed laminate ensures:

  • secure sealing during storage and transport
  • predictable and user-friendly opening
This parameter is specific to laminated strip foils and does not apply to standard blister lidding foils.

Key Foil Properties That Influence Seal Integrity

Seal integrity is highly dependent on the following foil characteristics:

1. Heat-Seal Coating Consistency

The coating layer must be uniform and precisely controlled.

Variations can lead to:

  • uneven sealing
  • weak bond areas
  • increased risk of leakage

2. Coating–Substrate Compatibility

The coating formulation must match the forming film or laminate structure.

Incorrect compatibility may result in:

  • poor adhesion
  • seal failure under stress

3. Foil Surface Quality

Surface defects such as pinholes, contamination, or irregularities can compromise sealing.

High-quality foils ensure:

  • clean, defect-free surfaces
  • reliable contact during sealing

4. Barrier Properties

Aluminum foil must provide a strong barrier against:

  • moisture
  • oxygen
  • light

Any compromise in barrier integrity increases product vulnerability.

Seal Integrity Testing from a Material Perspective

While testing is performed at the packaging level, results often reflect material performance.

1. Seal Strength Testing (Blister)

Evaluates the bond quality achieved by the foil coating with the forming film.

2. Peel Strength Testing (Strip Packaging)

Measures the separation force in laminated structures, indicating lamination consistency.

3. Dye Penetration & Leak Testing

Helps identify micro-defects that may originate from:

  • coating inconsistency
  • surface imperfections
  • material variability

These tests are essential for validating both material selection and supplier consistency.

Common Material-Related Causes of Seal Failure

Many seal failures originate from foil-related issues rather than process errors:

  • inconsistent heat-seal coating application
  • poor coating adhesion properties
  • variation between production batches
  • surface contamination or defects
  • inadequate lamination quality (in strip foils)
Selecting a reliable foil supplier with controlled manufacturing processes significantly reduces these risks.

Regulatory Expectations

Regulatory authorities expect pharmaceutical companies to ensure that packaging materials consistently meet defined performance standards.

This includes:

  • qualification of packaging materials
  • validation of sealing performance
  • documentation of material specifications

Foil quality, coating consistency, and supplier reliability are therefore critical components of regulatory compliance.

Role of High-Quality Foils in Packaging Reliability

Consistent seal integrity is not achieved by process control alone—it requires high-quality, precisely engineered aluminum foils.

Pharmaceutical-grade foils should offer:

  • uniform heat-seal coating
  • reliable bonding performance
  • excellent barrier protection
  • batch-to-batch consistency

These attributes enable stable sealing performance across high-speed production lines and global supply chains.

Strengthening Seal Integrity Through Material Excellence

Seal integrity is a fundamental requirement in pharmaceutical packaging. While sealing parameters and equipment play a role, material quality—especially aluminum foil performance—is a primary driver of reliability.

By selecting the right foil structures, ensuring coating compatibility, and maintaining strict quality standards, manufacturers can significantly reduce packaging risks.

Strong seal integrity helps:

  • protect product stability
  • minimize recalls and complaints
  • meet global regulatory requirements
  • ensure patient safety

Sanwariya Packaging supports these outcomes by supplying pharmaceutical aluminum foils designed for consistent coating performance, reliable sealing compatibility, and high barrier protection. With controlled manufacturing processes and strict quality standards, Sanwariya Packaging enables pharmaceutical companies to achieve dependable packaging performance at scale.

Essential Guide to Better Seal Integrity in Pharma Packaging

Author

Jay Wadhwani

Read More
Packaging foil for effervescent and hygroscopic drug products

Some pharmaceutical formulations are extremely sensitive to moisture. Effervescent tablets, dispersible medicines, and hygroscopic products are designed to interact with water or naturally absorb moisture from the surrounding environment. While this property is essential for how the medicine functions, it also creates a significant challenge during storage and distribution.

Even a small amount of moisture entering the package can compromise product stability long before the labeled expiry date. Tablets may soften, chemical reactions may begin prematurely, or the active ingredient may gradually degrade.

For this reason, selecting the right packaging foil for hygroscopic and moisture-sensitive medicines is not simply a packaging decision. It is a critical part of the overall stability strategy used by pharmaceutical manufacturers to ensure product safety, efficacy, and shelf-life reliability.

This blog explains why moisture protection is essential, how barrier performance is measured, and what foil structures are commonly used to protect highly sensitive pharmaceutical formulations used in modern pharmaceutical packaging solutions.

Why Effervescent Medicines Require Strong Moisture Protection

Effervescent tablets are specifically designed to dissolve rapidly when placed in water. This reaction occurs because the formulation typically contains ingredients such as acids and carbonates that react in the presence of moisture, producing carbon dioxide and enabling quick dissolution.

While this reaction improves patient convenience and drug absorption, it also creates a challenge during storage. If moisture enters the package prematurely, the same reaction designed for patient use can begin inside the blister cavity.

Possible consequences include:

  • Tablets swelling or cracking
  • Loss of mechanical strength
  • Reduced dissolution performance
  • Degradation of the active pharmaceutical ingredient
  • Visible changes in texture or appearance

Once this reaction begins, it cannot be reversed. Even minimal moisture exposure can compromise the medicine, making reliable packaging protection essential when selecting high-quality blister foils.

Hygroscopic Medicines: Constant Exposure to Humidity

Hygroscopic medicines behave slightly differently from effervescent formulations. Instead of reacting immediately with water, they gradually absorb moisture from the surrounding air.

This process can lead to several stability issues over time:

  • Tablets becoming soft or sticky
  • Powders forming lumps or aggregates
  • Changes in tablet weight due to moisture absorption
  • Reduced stability of moisture-sensitive active ingredients

These problems become even more pronounced in regions with high humidity. In tropical climates, where environmental moisture levels remain consistently elevated, packaging must provide stronger protection to maintain product integrity throughout its shelf life.

For pharmaceutical companies distributing medicines globally, packaging must perform reliably across different climates, transportation conditions, and storage environments.

Understanding WVTR and Why It Matters

To determine how effectively a packaging material protects against moisture, scientists measure a parameter called the Water Vapor Transmission Rate (WVTR).

WVTR measures the amount of water vapor that can pass through a packaging material over a specific period of time. Lower WVTR values indicate stronger resistance to moisture penetration.

“WVTR = mass of water vapor transmitted / (area × time)”

For highly moisture-sensitive medicines, even small differences in WVTR can significantly affect long-term stability. A packaging structure with slightly higher moisture permeability may allow gradual vapor ingress over months of storage.

Pharmaceutical packaging teams therefore evaluate WVTR data carefully when selecting blister materials. Stability studies are typically conducted to confirm that the chosen packaging maintains product quality throughout the intended shelf life.

Why Standard Blister Packaging May Not Be Enough

Standard blister packaging materials work well for many pharmaceutical products. However, for medicines that are extremely sensitive to moisture, these materials may not always provide sufficient protection.

Potential limitations include:

  • Gradual moisture penetration during long storage periods
  • Reduced protection in humid environments
  • Increased stability risks during long distribution routes

These risks are particularly relevant when products travel through extended supply chains or remain in storage for months before reaching patients.

For effervescent and hygroscopic formulations, packaging developers often prefer higher-barrier structures that significantly reduce the risk of moisture ingress using specialized pharmaceutical blister foils.

Foil Structures Commonly Used for Moisture-Sensitive Medicines

1. Aluminum–Aluminum Blister Systems

Aluminum-aluminum (Alu-Alu) blister packs use aluminum foil for both the forming layer and the lidding foil. Aluminum acts as an almost complete barrier against moisture, oxygen, and light.

Because of this property, Alu-Alu blisters are widely used for highly sensitive pharmaceutical formulations that require maximum protection.

These systems are typically manufactured using cold forming foils, which create the deep blister cavities while preserving the aluminum barrier structure.

2. Cold-Form Blister Foil

Cold-form blister packaging is produced without applying heat during the cavity-forming process. This preserves the integrity of the aluminum barrier and provides excellent protection against environmental exposure.

Cold-form blisters are often selected for medicines that must maintain strict stability profiles. High-barrier cold forming aluminum foils are commonly used for such applications.

3. High-Barrier Laminated Foils

In some cases, laminated foil structures combine aluminum with additional layers that enhance mechanical strength, sealing performance, and process efficiency during blister packaging operations.

These multilayer structures help balance barrier performance with manufacturing reliability. Pharmaceutical companies often evaluate strip laminated foils and advanced multi-layer foils when developing high-barrier packaging solutions.

In specialized applications, materials such as glassine foils may also be evaluated depending on packaging design and product requirements.

The final selection typically depends on several factors, including product sensitivity, shelf-life requirements, regulatory expectations, and distribution conditions.

Common Packaging Failures With Moisture-Sensitive Medicines

Even when a medicine is well formulated, packaging failures can still compromise stability if the packaging system is not properly designed.

Some common issues include:

1. Insufficient Moisture Barrier

Using materials with higher WVTR than required can allow gradual moisture penetration over time, particularly in humid environments.

2. Poor Seal Integrity

Inconsistent sealing during blister packaging can create microscopic channels where moisture may enter the package.

3. Variations in Foil Quality

Differences in foil thickness, coating quality, or lamination consistency may reduce the barrier performance across production batches.

4. Environmental Exposure During Distribution

High humidity levels during transportation or storage can place additional stress on the packaging system, especially during long shipping routes.

These issues may eventually lead to product complaints, stability failures, or regulatory concerns.

The Importance of Supplier Quality in Foil Selection

Selecting the right foil structure is only part of ensuring packaging reliability. The manufacturing consistency of the foil supplier is equally important.

Pharmaceutical companies typically expect packaging suppliers to provide:

  • Consistent barrier performance across batches
  • Reliable technical specifications
  • Traceability and quality documentation
  • Manufacturing systems aligned with pharmaceutical standards

Consistent material quality ensures that packaging performs the same way across every production cycle, which is critical for regulatory compliance and product stability. Advanced manufacturing capabilities and process control systems such as those used in modern pharmaceutical packaging infrastructure help ensure consistent foil quality.

Export Considerations for Humid Markets

Moisture protection becomes even more important when medicines are exported to humid regions around the world.

Countries located in tropical and coastal environments often experience high humidity levels throughout the year. During long shipping routes, medicines may also pass through multiple climate conditions before reaching the final market.

Packaging with strong moisture barriers helps pharmaceutical companies maintain product stability throughout these distribution journeys while reducing the risk of stability deviations after arrival.

Packaging as a Stability Strategy

Effervescent and hygroscopic medicines illustrate a fundamental principle in pharmaceutical product development: packaging must be designed with stability in mind.

Choosing the right moisture-barrier foil for pharmaceutical packaging allows companies to:

  • Protect sensitive formulations from environmental moisture
  • Maintain product performance throughout the labeled shelf life
  • Reduce the risk of stability failures
  • Support regulatory compliance across multiple markets

When packaging design is aligned with formulation sensitivity, pharmaceutical companies can ensure that medicines remain safe, effective, and reliable for patients worldwide.

How Sanwariya Packaging Supports Moisture-Sensitive Medicines

Sanwariya Packaging develops pharmaceutical aluminum foils designed to meet the demanding stability requirements of moisture-sensitive medicines. With high-barrier foil structures, consistent material quality, and strong process control supported by advanced manufacturing infrastructure, the company supports pharmaceutical manufacturers in protecting sensitive formulations throughout storage and global distribution.

Companies evaluating packaging materials can explore the complete range of pharmaceutical foil products or directly request a quote for customized packaging solutions.

Best Foil for Moisture-Sensitive Medicines (Complete Guide)

Author

Jay Wadhwani

Read More